(a) Information received by the department, the commission or the Department of Public Health, through filed reports or inspection or as otherwise authorized under chapters 418, 420b, 420c and 420f and sections 20-570 to 20-630, inclusive, shall not be disclosed publicly in such a manner as to identify individuals or institutions, except: (1) In a proceeding involving the question of licensure or the right to practice; and (2) in a proceeding where the commission has voted in favor of formal disciplinary action against a pharmacist or pharmacy licensed pursuant to this chapter, when such disciplinary action is related to an error in the dispensing of medication. Nothing in this section shall be construed to prohibit the commissioner from disclosing information gained through the inspection of pharmacies and outlets holding permits for the sale of nonlegend drugs if the commissioner considers such disclosure to be in the interest of public health.
(b) Notwithstanding the provisions of subsection (a) of this section, section 21a-265 and chapter 55, the Commissioners of Consumer Protection and Public Health and the authorized agents of said commissioners, in carrying out their duties under subsection (a) of this section, may: (1) Exchange information relating to a license or registration issued by their respective agencies; or (2) exchange investigative information relating to violations of this chapter with each other, the Chief State's Attorney and any agencies charged with enforcing the pharmacy or drug laws of the United States, this state or other jurisdictions.
(1969, P.A. 593, S. 8; P.A. 77-614, S. 323, 610; P.A. 87-204; P.A. 93-381, S. 9, 39; P.A. 95-257, S. 12, 21, 58; 95-264, S. 9; P.A. 99-175, S. 13; P.A. 07-252, S. 73; P.A. 09-150, S. 1; P.A. 22-104, S. 30.)
History: P.A. 77-614 replaced department of health with department of health services, effective January 1, 1979; Sec. 19-504h transferred to Sec. 21a-306 in 1983; P.A. 87-204 added provision re disclosure of information deemed to be in the interest of public health; P.A. 93-381 authorized substitution of department of public health and addiction services for department of health services, effective July 1, 1993; P.A. 95-257 replaced Commissioner and Department of Public Health and Addiction Services with Commissioner and Department of Public Health, effective July 1, 1995; P.A. 95-264 made technical changes to conform language to similar provisions throughout statutes; Sec. 21a-306 transferred to Sec. 20-578 in 1997; P.A. 99-175 made technical changes and replaced reference to Sec. 20-625 with reference to Sec. 20-630; P.A. 07-252 designated existing provisions as Subsec. (a) and added Subsec. (b) authorizing exchange of information among Commissioners of Consumer Protection and Public Health, the Chief State's Attorney and other agencies charged with enforcing pharmacy or drug laws; P.A. 09-150 amended Subsec. (a) by adding Subdiv. (2) re exemption for information in proceeding where disciplinary action is related to an error in dispensing medication and by making a conforming change; P.A. 22-104 amended Subsec. (a) by adding references to Chs. 420c and 420f, and made technical and conforming changes, effective May 24, 2022.
Annotation to former section 21a-306:
For purposes of statute, compliance meetings are not “proceedings” and documents relating to such meetings were exempt from disclosure. 207 C. 698.
Structure Connecticut General Statutes
Section 20-570. - Short title: Pharmacy Practice Act.
Section 20-571. (Formerly Sec. 20-184a). - Definitions.
Section 20-572. (Formerly Sec. 20-163). - Commission of Pharmacy. Appointment and term of members.
Section 20-573. (Formerly Sec. 20-165). - Meetings of commission. Records.
Section 20-574. (Formerly Sec. 20-164a). - Supervision by Commissioner of Consumer Protection.
Section 20-575. - Powers and responsibilities.
Section 20-576. (Formerly Sec. 20-164). - Regulations.
Section 20-576a. - Acceptance and disposal of unused prescription drugs at pharmacies. Regulations.
Section 20-578. (Formerly Sec. 21a-306). - Information not to be disclosed. Exception.
Section 20-580. (Formerly Sec. 20-167). - Revocation or suspension of nonlegend drug permit.
Section 20-581. (Formerly Sec. 20-185). - Penalty for violation of Pharmacy Practice Act. Exception.
Section 20-582. (Formerly Sec. 20-176). - Appeals of decisions of Commission of Pharmacy.
Section 20-583. - Where appeals returnable.
Section 20-591. - Graduates of foreign pharmacy schools. Regulations.
Section 20-596. (Formerly Sec. 20-168b). - Ownership of pharmacies by prescribing practitioners.
Section 20-598. (Formerly Sec. 20-177). - Registration of pharmacy interns.
Section 20-598a. - Registration and certification of pharmacy technicians.
Section 20-599. (Formerly Sec. 20-174a). - Continuing education: Definitions.
Section 20-605. - Practice of pharmacy without license or temporary permit prohibited.
Section 20-606. (Formerly Sec. 20-178). - Use of the title “pharmacist”.
Section 20-611. (Formerly Sec. 20-175b). - Advertising legend drug prices.
Section 20-612. - Only pharmacy may accept prescription for dispensing.
Section 20-617a. - Flavoring agent added to prescription product.
Section 20-618. (Formerly Sec. 21a-107). - Repackaged drugs not considered misbranded, when.
Section 20-623. - Sale of nonlegend drugs. Labels, packaging and contents. Penalty.
Section 20-624. - Permit to sell nonlegend drugs.
Section 20-625. - Nonlegend veterinary drugs.
Section 20-626. - Confidentiality of pharmacy records.
Section 20-627. - Nonresident pharmacy. Definitions. Certificate of registration. Requirements.
Section 20-628. - Shipping, mailing or delivering legend devices or drugs.
Section 20-630. - Advertising.
Section 20-633. - Administration of vaccines by licensed pharmacists. Regulations.
Section 20-633a. - Pharmacy rewards program. Plain language summary. Violation.
Section 20-633b. - Sterile compounding pharmacies. Requirements. Regulations.
Section 20-633c. - Prescribing of opioid antagonists by licensed pharmacists. Regulations.
Section 20-633i. - Issuance of prescriptions for epinephrine auto injectors by pharmacists.
Section 20-636. - Sign re storage and disposal of prescription drugs.